Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Mar. 31, 2013
Revenues $ 0 $ 0 $ 0 $ 390
Operating expenses:        
Research and development (related party of $124, $82, $430 and $301) 343 631 1,480 2,464
Research and development - effect of Settlement Agreement (Note 6) 0 0 (1,041) 0
General and administrative 951 1,229 2,950 3,291
General and administrative - effect of Settlement Agreement (Note 6) 0 0 (700) 0
Total operating expenses 1,294 1,860 2,689 5,755
Operating loss (1,294) (1,860) (2,689) (5,365)
Other income (expense):        
Interest income 3 1 7 7
Interest expense 0 (15) 0 (48)
Interest expense - effect of Settlement Agreement (Note 6) 0 0 122 0
Royalty income 9 7 34 22
Other income 3 0 3 0
Loss on disposal of fixed assets 0 0 (1) 0
Change in fair value of warrant derivative liability 0 109 0 503
Total other income 15 102 165 484
Net loss $ (1,279) $ (1,758) $ (2,524) $ (4,881)
Loss per common share - basic and diluted (in dollars per share) $ (0.02) $ (0.04) $ (0.04) $ (0.10)
Weighted-average common shares outstanding - basic and diluted (in shares) 65,642 47,767 62,080 47,767